Senior Manager, Upstream MSAT

Summit Therapeutics•Princeton, NJ

1d•$148,000 - $175,000•Onsite

About The Position

Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.

Requirements

Degree in chemical engineering, biotechnology, pharmaceutical science, or a related field. Bachelor’s degree with 10+ years of relevant experience; Master’s degree with 8+ years of relevant experience; PhD with 6+ years of relevant experience.
Experience with CHO mammalian cell culture processes, including seed train operations, production bioreactors, media and feed strategies, process scale-up, harvest clarification, technology transfer, and commercial manufacturing support.
Direct experience in process scale-up and technology transfer across scales, systems, and manufacturing sites, including transfer from development through commercial manufacturing; experience with large-scale (>10 kL) stainless steel bioreactors and centrifugation transfer is a plus.
Demonstrated experience performing facility fit assessments, including evaluation of process equipment, critical raw materials, utilities, and manufacturing capabilities to support successful technology transfer and commercialization.
Experience in late-stage process development, characterization and validation is highly valued
Proficiency in data analysis and statistical tools (e.g., JMP, DOE, multivariate analysis) to support process understanding and data-driven decision-making.
Strong communication, interpersonal, and project management skills, with the ability to work independently, operate effectively in a matrixed environment, and manage multiple priorities under tight timelines.
Good information management and data organization skills
Exceptional interpersonal skills with the ability to work individually, within a multi-disciplinary team, as well as with external partners and regulators.
A track record of working under pressure and delivering high-quality results to tight deadlines.

Nice To Haves

Experience authoring IND/IMPD and BLA/MAA Module 3 content, as well as CPV (Continued Process Verification), is highly preferred.

Responsibilities

Provide technical support and leadership for upstream process characterization, validation, and commercial manufacturing support, including process optimization and troubleshooting.
Lead technology transfer activities across internal teams and CDMOs, including scale-up, PPQ execution, and commercial readiness, serving as the primary technical interface with external partners.
Support clinical and commercial manufacturing by ensuring alignment with development timelines, supply plans, and operational readiness.
Assess and manage process risks and lifecycle changes, including risk assessments, deviation investigations, root cause analysis, CAPA, and change control.
Author and review regulatory submissions (IND/IMPD/BLA/MAA Module 3 sections) and provide technical support for health authority interactions.
Oversee PPQ execution and commercial manufacturing support, including person-in-plant activities, ensuring GMP compliance, data integrity, and inspection readiness (PLI/PAI).
Lead change control activities, including impact assessments, and collaborate with Quality and Technical Operations on the development and execution of implementation plans.
Drive continuous improvement initiatives to enhance process robustness, scalability, and operational efficiency.
Travel as needed to support manufacturing, technology transfer, and CDMO oversight.
Perform other duties as assigned.